Skip to content
Life Sciences Series B Founded 2013

Oculogica

Oculogica provides eye-tracking technology that detects proper brain functioning. Oculogica’s EyeBox CNS is authorized by the FDA as an aid in the diagnosis of concussion. Its technology detects weaknesses of the specific cranial nerves that move the eye, and the signature of palsies in any given patient informs regarding the location and nature of their pathology. Its solution requires no baseline data or…

📍 New York City, United States · Neurology,

Funding snapshot

Last roundSeries B
Amount$8M
Date26 April 2024
Total raised$22M
Team size13

About

Oculogica provides eye-tracking technology that detects proper brain functioning. Oculogica’s EyeBox CNS is authorized by the FDA as an aid in the diagnosis of concussion. Its technology detects weaknesses of the specific cranial nerves that move the eye, and the signature of palsies in any given patient informs regarding the location and nature of their pathology. Its solution requires no baseline data or individual calibration, so the results cannot be influenced by a patient's will. The company operates in the Neurology sector with additional focus on Healthcare IT and Eye Tracking. Its business model centers on Healthcare. Founded in 2013, headquartered in New York City, United States. The company has raised $22.0M at the Series B stage. Backed by investors including TitletownTech, HHS, Colle Capital, Sofia Fund, Lateral Capital and others.

Business model

Eye Tracking > Applications > Healthcare,

Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Diagnostics and Assessment Tests > Cognitive Assesment > Eye tracking,

Neurology > Medical Devices > Screening Devices > Eye Tracking

Institutional investors

TitletownTech HHS Colle Capital Sofia Fund Lateral Capital Golden Seeds Seraph Group Design Technologies Quark Venture Southeast Minnesota Capital Fund

Latest coverage

No articles yet.

Raising like Oculogica?

Analyze your pitch deck before your next raise.

Analyze My Deck →